Qi Cao Selected Research

Creatinine

1/2015	Comparison of methods for renal risk prediction in patients with type 2 diabetes (ZODIAC-36).
5/2012	Lipopolysaccharide-pretreated plasmacytoid dendritic cells ameliorate experimental chronic kidney disease.
6/2011	Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi Cao Research Topics

Disease

65	Neoplasms (Cancer) 05/2022 - 07/2006
36	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2003
23	Inflammation (Inflammations) 01/2022 - 03/2004
20	Fibrosis (Cirrhosis) 01/2021 - 10/2003
17	Neoplasm Metastasis (Metastasis) 01/2022 - 11/2006
14	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2017
11	Infections 12/2021 - 02/2014
8	Carcinogenesis 01/2022 - 11/2005
7	Breast Neoplasms (Breast Cancer) 01/2022 - 09/2003
6	Atherosclerosis 08/2022 - 01/2017
6	Proteinuria 01/2022 - 09/2008
6	Kidney Diseases (Kidney Disease) 01/2020 - 07/2013
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 04/2002
5	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 01/2018
5	Insulin Resistance 01/2019 - 03/2004
5	Alcoholic Fatty Liver 01/2012 - 03/2004
4	Bites and Stings (Sting) 12/2022 - 01/2021
4	Glomerulonephritis 01/2022 - 12/2007
4	Necrosis 01/2022 - 05/2002
4	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2009
4	Pneumonia (Pneumonitis) 01/2021 - 11/2017
4	Chronic Renal Insufficiency 01/2021 - 05/2012
4	Reperfusion Injury 01/2021 - 01/2018
4	Fatty Liver 01/2020 - 03/2008
4	Kidney Neoplasms (Kidney Cancer) 01/2019 - 01/2017
4	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2012 - 12/2002
4	Ovarian Neoplasms (Ovarian Cancer) 04/2009 - 07/2006
3	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 12/2006
3	Hypoxia (Hypoxemia) 01/2022 - 04/2009
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2021 - 10/2016
3	Obesity 02/2020 - 01/2017
3	Glioma (Gliomas) 11/2019 - 12/2015
3	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 11/2019 - 12/2007
3	Nephrosis 10/2013 - 06/2008
2	Hemorrhage 01/2022 - 05/2017
2	IGA Glomerulonephritis (IGA Nephropathy) 01/2022 - 03/2012
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 05/2010

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
21	CytokinesIBA 04/2022 - 05/2002
17	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2008
16	Messenger RNA (mRNA)IBA 01/2021 - 03/2004
10	Biological ProductsIBA 01/2021 - 08/2006
8	Long Noncoding RNAIBA 07/2021 - 07/2011
8	AndrogensIBA 01/2021 - 08/2007
7	RNA (Ribonucleic Acid)IBA 08/2022 - 07/2011
7	LipidsIBA 05/2022 - 01/2018
7	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 01/2017
7	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 10/2009
6	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 02/2013
6	Ethanol (Ethyl Alcohol)IBA 01/2022 - 12/2002
6	CateninsIBA 01/2021 - 01/2016
6	CollagenIBA 01/2020 - 01/2006
6	MicroRNAs (MicroRNA)IBA 04/2019 - 06/2011
6	Insulin (Novolin)FDA Link 01/2019 - 03/2004
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2018 - 12/2002
5	Therapeutic UsesIBA 01/2021 - 09/2010
5	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2010
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 06/2008
5	AntigensIBA 01/2019 - 02/2013
5	Phosphotransferases (Kinase)IBA 01/2019 - 07/2006
4	EnzymesIBA 12/2022 - 03/2008
4	Pharmaceutical PreparationsIBA 08/2022 - 11/2011
4	Estrogens (Estrogen)FDA Link 01/2022 - 11/2006
4	Hormones (Hormone)IBA 01/2021 - 11/2008
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2021 - 01/2014
4	Polycomb-Group ProteinsIBA 10/2020 - 09/2003
4	Sunitinib (Sutent)FDA Link 09/2020 - 01/2017
4	VaccinesIBA 09/2020 - 12/2008
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 03/2010
4	LipopolysaccharidesIBA 01/2020 - 05/2012
3	Antiviral Agents (Antivirals)IBA 12/2022 - 01/2021
3	Peptides (Polypeptides)IBA 08/2022 - 05/2020
3	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2018
3	Estrogen ReceptorsIBA 01/2022 - 06/2009
3	Small Interfering RNA (siRNA)IBA 10/2021 - 04/2009
3	fucoidanIBA 09/2021 - 03/2019
3	ICG 001IBA 01/2021 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 04/2015
3	AntioxidantsIBA 12/2020 - 01/2006
3	ChemokinesIBA 11/2019 - 12/2008
3	Complement System Proteins (Complement)IBA 11/2018 - 06/2012
3	NF-kappa B (NF-kB)IBA 01/2018 - 07/2006
3	Matrix Metalloproteinases (MMPs)IBA 05/2017 - 01/2007
3	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 07/2009
3	CreatinineIBA 01/2015 - 06/2011
3	Proto-Oncogene Proteins c-etsIBA 10/2012 - 01/2008
3	Progestins (Progestagens)IBA 04/2009 - 11/2006
3	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 10/2007 - 07/2005
3	Tissue Inhibitor of Metalloproteinase-1IBA 01/2007 - 03/2006
2	A-Form DNA (A-DNA)IBA 04/2022 - 11/2021
2	Interleukin-33IBA 01/2022 - 01/2018
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 01/2022
2	Immunoglobulin A (IgA)IBA 01/2022 - 03/2012
2	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 05/2010
2	celastrol methyl esterIBA 12/2021 - 05/2010

Therapy/Procedure

24	Therapeutics 01/2022 - 12/2007
9	Castration 01/2021 - 06/2017
4	Immunotherapy 11/2021 - 01/2018
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 08/2022 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2021 - 06/2017